6-Chloro-7-(4-(4-chlorobenzyl)piperazin-1-yl)-2-(1,3-dimethyl-1Hpyrazol-4-yl)-3H-imidazo[4,5-b] pyridine (CCT241736, also referred to as Compound 27e in Bavetsias et al. (2012)), is a dual FLT3 and Aurora kinase inhibitor in pre-clinical development for the treatment of AML. Here, FLT3 is linked to acute myeloid leukemia.